Emerging Nanoscale Materials for Cancer Diagnosis and Therapy
A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".
Deadline for manuscript submissions: 10 October 2024 | Viewed by 99
Special Issue Editors
Interests: nanoparticles; skin cancer and melanoma genetics; novel delivery systems for biomedical applications; immunomodulating agents; nanovaccine; cancer therapy
Special Issues, Collections and Topics in MDPI journals
Interests: nanomedicine; stem cells; novel immunoadjuvants; stimuli-responsive nanosystems; targeted therapy; influenza vaccines
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The solicitation extends an invitation to contribute to a Special Issue focused on "Emerging Nanoscale Materials for Cancer Diagnosis and Therapy", reflecting the growing momentum of nanotechnology in cancer research.
Clinical investigations are actively exploring nanomaterials for therapeutic and diagnostic applications, with nanodiagnostics showing promise in enhancing tumor detection sensitivity and enabling early diagnosis. A diverse array of nanomaterials, including quantum dots, polymeric nanoparticles, carbon nanotubes, and dendrimers, are being utilized in cancer diagnosis, with the enhancement of cancer detection capabilities achieved through the conjugation of nanoparticles with cell surface receptor targeting molecules like aptamers and antibodies. In the realm of cancer therapeutics, nanotechnology aims to improve pharmacokinetics and mitigate systemic toxicities of chemotherapies, immune modulators, and photosensitizers by selectively delivering these agents to the tumor microenvironment. Nanoformulations, wherein therapeutic moieties are encapsulated or conjugated to the surface of nanoparticles, offer a means to enhance the therapeutic index of delivered drugs. Furthermore, nanoparticles have garnered significant interest for photodynamic therapy (PDT) and photothermal therapy (PTT), enabling site-specific delivery of phototherapy agents to tumors and facilitating photothermal ablation of tumor cells, particularly through the utilization of inorganic nanomaterials like gold nanoparticles, iron oxide nanoparticles, and copper sulfate with potent photothermal properties. This Special Issue aims to be a comprehensive collection of works related to nanomedicine and their application in cancer theragnostic. Therefore, we invite authors to contribute with original research articles and review articles covering the current progress in cancer nanomedicine. Potential topics include but are not limited to:
- Cancer cell detection with nanomedicine;
- Nanoparticle for drug delivery;
- PDT with nanomedicine;
- PTT effect of nanomedicine;
- Nanomedicine as an immunomodulator;
- Nanoparticle for cancer cell imaging.
Dr. Kishwor Poudel
Dr. Asmita Banstola
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanotechnology
- PDT
- PTT
- photosensitizer
- immune modulator
- theragnostic
